It is worth noting that 2 of 19 genes, ECI2 and TMCO3, clearly exhibited tumor-suppressive potential in neuroblastoma patients, with their low expressions correlated with poorer patient survival in both datasets. Here, SLC9D1 is linked to neoplasm.